21 results
S-1
EX-10.7
GLTO
Galecto Inc
7 Oct 20
IPO registration
5:01pm
Assessment of device opportunities completed
25% of Target Bonus :
0 Validation of second indication for Gal-3 inhibitors
0 Hire Chief Medical
10-Q
2020 Q3
GLTO
Galecto Inc
11 Dec 20
Quarterly report
7:30am
;
our ability to retain the continued service of our key professionals and consultants and to identify, hire and retain additional qualified … expenses to increase as we continue our development of, and seek regulatory approvals for, our product candidates, as well as hire additional personnel
10-K
f67rs8jye onr
29 Mar 21
Annual report
6:03am
S-1/A
a5u 1iavwcsn
22 Oct 20
IPO registration (amended)
6:13am
DRS
dwd1i9w6pgj pcx
2 Sep 20
Draft registration statement
12:00am
424B4
k8suq6tsk0h 4jw9yo
30 Oct 20
Prospectus supplement with pricing info
4:31pm
S-1
utvvhxm
7 Oct 20
IPO registration
5:01pm
S-3
j2k5ro 6kmwwl
4 Nov 21
Shelf registration
4:59pm
S-1
EX-4.2
4ren4cfx4dx8k8
7 Oct 20
IPO registration
5:01pm